UCB Pharma × Epilepsy
UCB Pharma epilepsy: 3 indexed trials, 0 recruiting studies across 3 countries in the current NeuroRisk corpus.
Request comparative brief →Indexed trials3
Recruiting0
Countries3
Indexed studies
NCT00160654Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
Hong KongPHASE4
Hong KongPHASE4
NCT00175929A Study of Brivaracetam in Subjects With Partial Onset Seizures
BelgiumPHASE2
BelgiumPHASE2
NCT00319605Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
SpainCOMPLETED
SpainCOMPLETED
Enterprise comparison
Compare sponsor momentum, recruiting activity, geography and connected evidence with the broader NeuroRisk intelligence layer.
Request enterprise access →